Deals

Salesforce agreed to pay $47.50 a share for Braze, whose SEC-filed FAQ leaves renewal terms undecided

Three weeks after Salesforce agreed to buy Braze for $5.66 billion, the seller's own SEC-filed sales script promises enterprise buyers nothing beyond today's contracts while its account teams push multi-year renewals. For BRZE holders the stock is now a claim on $47.50 in cash, and the deal documents price the wait.

Richard TangRichard Tangthree-minute read
Share
Bill Magnuson, chief executive and cofounder of Braze, smiling in a portrait against a pink background
Bill Magnuson, Braze's chief executive and cofounder, leads the insiders holding about 5% of the vote who are locked behind the Salesforce deal.

The most checkable document in the Salesforce−3.11% — Salesforce, down 3.11 percent today-Braze−0.40% — Braze, down 0.40 percent today deal is the vendor's own sales script. On November 10, three weeks after Salesforce agreed to buy Braze for $5.66 billion, Braze filed the customer FAQ its account teams use as soliciting material with the SEC, and its sixth question is the one renewals hinge on: why sign a multi-year deal if this closes next year 12?

The answer promises no changes to the renewal process or to existing contracts, then concedes the entire integration story is "possibilities, and no decisions have been made yet" 1. The capability has been bought. The work of turning it into anything a marketer uses is undecided, in the seller's own words.

The promises stop at today

Every commitment in the FAQ is in the present tense: no changes to products, service or support, "no impact on our pricing," contracts renewed through the normal process 1. Read the nouns and they cover today's paper and nothing further. Nothing filed promises the price holds at the next renewal, that a term signed now runs its full length after the close, or that the packaging survives integration.

That is honest, not evasive: a company operating under a merger agreement cannot commit to post-closing terms. But multi-year pricing is normally a discount bought with term, and the vendor's on-record answer defers exactly the substance of that trade 3.

What Salesforce bought is undecided work

The attraction is mechanical. Braze's real-time engagement data and its AI decisioning layer would slot into Salesforce's four layers: Data 360 for data, Customer 360 for the profile, Agentforce for the agents that act on lifecycle signals 1. Follow the chain and campaigns stop running on a calendar and start triggering on behavior. The filing itself refuses to underwrite that far end, and even "Braze will continue building as Braze" is a hope, not a term 1.

The documents price the wait

The proxy is due November 23, thirty-five days after signing, and Braze's SEC index shows none filed yet 47. Braze owes $191 million if it leaves for a superior offer 5. Salesforce owes $300 million if antitrust kills the deal 5. The outside date can stretch to April 16, 2028 4. Insiders holding about 5% of the vote, led by chief executive Bill Magnuson, are locked behind the deal, which needs a majority of outstanding Class A shares 56. Braze reports on December 8 with no call and no guidance 8.

BRZE trades about a dollar under the $47.50 cash exit

$0$20$40$6019 Oct close20 Oct close19 Nov intradayDeal price$47.5$46.35
Data
BRZE share price
19 Oct close$30.04
20 Oct close$45.57
19 Nov intraday$46.35
Deal price$47.5
BRZE closing prices either side of the October 20, 2026, announcement, the intraday quote on November 19, 2026, and the $47.50 per-share cash merger consideration. Source: CNBC.2

The buyer is cutting jobs while the clock runs

Salesforce (CRM) shares fell on November 18 on reports of a fresh round of layoffs, and the stock sits nearly 30% below its high for the year; BTIG cut its target to $250 on AI-disruption worries 9. BRZE traded around $46 on November 19, about a dollar under the $47.50 each share becomes at close 2.

The chain from engagement data to agents running lifecycle marketing still leads where it did in October. What the filing adds is the distance left: Salesforce has bought the capability, and everything between it and a marketer's Tuesday is still undecided work.

Get Deals by email, free

The acquisitions, rounds and contracts that move AI money. In our daily email, every weekday.

Loading BRZE

Reader comments

0 comments

    Deals

    Musk puts a Tesla-SpaceX merger at 25% within a year

    Prediction-market odds put the announcement in early 2027, and the pay agreement Musk signed in 2025 lets a rich deal price vest shares no operating goal has earned. The cost lands on Tesla holders, who also own the deciding vote.

    Deals

    Sacramento votes to renew Axon for $17.7 million and bar AI training on city camera data

    The renewal makes Sacramento own its camera data, opt out of Axon's AI training and bar default sharing with federal agencies. Spread across renewals, those terms reach the data advantage beneath the software Axon's beaten-down stock now leans on.

    Deals

    Merck buys AI drug designs from Isomorphic Labs two days after its $5 billion round

    MSD, Merck & Co. (NYSE: MRK) outside the United States and Canada, carries the clinical and commercial risk and pays an undisclosed upfront, milestones and tiered royalties, while Isomorphic Labs holds a new option to co-fund trials for elevated royalties. Two days after the largest life-science venture round ever, the deal hands Alphabet's (Nasdaq: GOOGL) AI drug spinout its fourth Big Pharma payer before any candidate has entered a human trial.

    Deals

    AMD closed Taalas at $2.9 billion, with $1.4 billion riding on undisclosed milestones

    AMD's completion release named no price; the quarterly filing that carries the terms makes up to $1.4 billion of the $2.9 billion contingent on conditions the company has not disclosed. It is the second AI acquisition in a fortnight, about $11.1 billion combined, by a stock trading above 100 times trailing earnings.

    Deals

    Cognizant won Network Rail's seven-year data center contract 28% under the buyer's own estimate

    The seven-year data-center award hands Cognizant volume in a weak market, but the buyer's own tender estimate shows a large UK public-sector deal clearing about 28% below budget, and the award notice offers no explanation.

    Deals

    Anthropic IPO nears $500 billion in orders before Nasdaq debut

    Anthropic closed its order books on Tuesday with roughly $400 billion of institutional interest and nearly $100 billion of retail interest, about seven times the shares on offer, and is guiding pricing above its $70–$78 range ahead of Thursday's Nasdaq debut under ANT. The final price lands after the US close tonight, and the money it moves reaches from IPO allocators to the chip and cloud suppliers holding guaranteed Anthropic contracts.

    Subscribe to TheInference for free